Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Ann N Y Acad Sci. 2008 Dec;1150:46–53. doi: 10.1196/annals.1447.009

Figure 1. Legend: Optimal human PBMC recipient.

Figure 1

Adult mice of the indicated stocks were injected intravenously with 20×106 human PBMC. Four weeks later, the percent of human CD45+ cells in the blood, and the percent and number of human CD45+ cells in the spleen were determined by flow cytometry.